Skip to content
The Policy VaultThe Policy Vault

Lynparza (olaparib tablets – AstraZeneca) — Cigna

Uterine Leiomyosarcoma

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Patient has BRCA2-altered disease; AND
  • Patient has tried at least one systemic regimen

Approval duration

1 year